04.27.21

Johnson & Johnson Vision Receives Approval in Canada for First Drug-Releasing Contact Lens for Vision Correction and Allergic Eye Itch

Source: Johnson & Johnson Vision

Johnson & Johnson Vision received Health Canada approval for the first and only daily disposable contact lens for vision correction in patients who experience itchy allergy eyes due to allergic conjunctivitis: Acuvue Theravision with Ketotifen.1 The lens contains an H1 histamine receptor antagonist for the prevention of itchy allergy eyes associated with allergic conjunctivitis experienced by contact lens users to promote comfortable contact lens wear. In March 2021, Acuvue Theravision with Ketotifen received its first regulatory approval from the Japanese Ministry of Health, Labour and Welfare.

“We are proud to mark another step forward in delivering this important innovation to help relieve patients from allergic eye itch while continuing to comfortably wear contact lenses,” Xiao-Yu Song, MD, PhD, Global Head of Research & Development, Johnson & Johnson Vision, said in a company news release. “We look forward to working with additional health authorities to make Acuvue Theravision with Ketotifen available to more patients around the world.”

Itchy allergy eyes can impact vision, and this becomes even more problematic for contact lens wearers – most of whom resort to rubbing their eyes.ǂ Data show that nearly 8 out of 10 contact lens wearers feel frustrated when their eye allergies interfere with normal contact lens wear. Acuvue Theravision with Ketotifen may help people continue to wear their contact lenses for vision correction, and prevent allergic eye itch, without the need for allergy eye drops.

References

JJV Data on File 2019. Mechanism of action, formulation, and comfort of ACUVUE® Theravision™ with Ketotifen

2 JJV Data on File 2021. Claim for the family of ACUVUE® OASYS Brand Contact Lenses (2-week reusable) and ACUVUE® OASYS 1-Day with HydraLuxe® Technology using clinical trials cited on www.clinicaltrials.gov website (February 25, 2021).

3 JJV Data on File 2020. Claim for ACUVUE® VITA® with HydraMax® Technology. Unbeaten in Comfort in Monthly Lens Category – using clinical trials cited on www.clinicaltrials.gov website (November 23, 2020).

4 JJV Data on File 2020. Unbeaten Comfort of 1-DAY ACUVUE® MOIST Family Brand Contact Lenses (December 21, 2020).

SOURCE Johnson & Johnson Vision

Related Content